Statin-associated necrotizing autoimmune myopathy with concurrent myasthenia gravis

Area of Science:

• Neurology
• Immunology
• Pharmacology

Background:

• Statin medications are widely prescribed for cholesterol management.
• Previous research suggests statins may be linked to autoimmune disorders.
• Necrotizing autoimmune myopathy and myasthenia gravis are distinct autoimmune conditions.

Observation:

• A patient developed symptoms suggestive of both necrotizing autoimmune myopathy and myasthenia gravis.
• The patient had recently been treated with statin medication.

Findings:

• This case presents a rare co-occurrence of necrotizing autoimmune myopathy and myasthenia gravis.
• The temporal association suggests a potential link between statin treatment and the development of these dual autoimmune myopathies.

Implications:

• This case underscores the importance of considering statin-induced autoimmune myopathies.
• Further investigation is warranted to elucidate the mechanisms linking statins to these complex autoimmune conditions.
• Clinicians should maintain a high index of suspicion for autoimmune myopathies in patients on statin therapy.